Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.92 $17.05 Thursday, 9th May 2024 SAGE stock ended at $12.34. This is 0.404% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.87% from a day low at $12.20 to a day high of $12.55.
90 days $10.92 $27.39
52 weeks $10.92 $59.98

Historical Sage Therapeutics prices

Date Open High Low Close Volume
Jul 25, 2023 $43.69 $43.82 $39.57 $41.84 3 182 127
Jul 24, 2023 $44.64 $44.73 $43.74 $43.95 559 888
Jul 21, 2023 $45.86 $46.27 $44.57 $44.73 420 558
Jul 20, 2023 $45.39 $45.89 $45.03 $45.53 624 489
Jul 19, 2023 $45.65 $46.43 $45.21 $45.59 727 612
Jul 18, 2023 $46.32 $46.52 $45.46 $45.90 487 290
Jul 17, 2023 $46.82 $47.78 $46.47 $46.47 453 030
Jul 14, 2023 $47.56 $48.15 $46.48 $46.59 362 901
Jul 13, 2023 $47.94 $48.68 $47.48 $47.59 455 705
Jul 12, 2023 $49.63 $49.63 $47.53 $47.73 524 936
Jul 11, 2023 $47.19 $49.27 $46.74 $48.98 885 272
Jul 10, 2023 $45.75 $47.65 $45.43 $47.32 657 813
Jul 07, 2023 $45.59 $46.70 $45.00 $45.76 801 313
Jul 06, 2023 $46.48 $46.84 $45.57 $45.59 735 087
Jul 05, 2023 $48.07 $48.41 $46.78 $47.14 977 833
Jul 03, 2023 $46.94 $48.19 $46.76 $48.17 405 666
Jun 30, 2023 $47.09 $47.35 $46.33 $47.02 629 823
Jun 29, 2023 $46.84 $47.76 $46.51 $46.97 944 150
Jun 28, 2023 $47.10 $47.16 $46.07 $46.84 925 380
Jun 27, 2023 $48.10 $48.38 $46.87 $47.05 889 511
Jun 26, 2023 $49.54 $50.19 $47.91 $47.93 770 809
Jun 23, 2023 $54.04 $54.17 $49.45 $49.76 2 503 013
Jun 22, 2023 $55.46 $56.37 $54.57 $54.60 533 901
Jun 21, 2023 $54.99 $55.61 $53.18 $55.22 475 073
Jun 20, 2023 $55.23 $56.00 $54.51 $55.38 499 970
Click to get the best stock tips daily for free!

About Sage Therapeutics

Sage Therapeutics Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment... SAGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT